| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,318 |
2,581 |
$1.36M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,831 |
3,188 |
$773K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
671 |
563 |
$452K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
619 |
511 |
$99K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,079 |
333 |
$81K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
803 |
715 |
$47K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
551 |
483 |
$42K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
475 |
411 |
$37K |
| 80053 |
Comprehensive metabolic panel |
296 |
228 |
$27K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
150 |
140 |
$25K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
204 |
81 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
2,890 |
2,203 |
$14K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
161 |
139 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
161 |
139 |
$12K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
182 |
173 |
$6K |
| 81514 |
|
14 |
13 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
349 |
267 |
$6K |
| 85027 |
|
374 |
297 |
$5K |
| 80061 |
Lipid panel |
176 |
137 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
26 |
13 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16 |
16 |
$4K |
| 87481 |
|
16 |
16 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
34 |
25 |
$3K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
69 |
66 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
16 |
16 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
56 |
54 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
29 |
29 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
59 |
53 |
$2K |
| 97161 |
|
12 |
12 |
$888.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
38 |
37 |
$793.80 |
| 87480 |
|
18 |
13 |
$742.86 |
| 87510 |
|
18 |
13 |
$742.86 |
| 87660 |
|
18 |
13 |
$742.86 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14 |
12 |
$232.54 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
27 |
25 |
$45.91 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
27 |
27 |
$44.28 |